September 4, 2024
Pfizer and Valneva Report Strong Immune Responses from Second Lyme Disease Vaccine Booster
Lyme disease, vaccine, Pfizer, Valneva, VLA15, booster, immune response, Phase 2 trials, FDA submission
ArsenalBio Secures $325M in Series C Funding for Solid Tumor Cell Therapy Trials
ArsenalBio, cell therapy, solid tumor trials, Series C funding, biotech investment
Biogen Announces Positive Results from Higher Dose Spinraza Study in Spinal Muscular Atrophy Patients
Biogen, Spinraza, spinal muscular atrophy, SMA, higher dose, clinical trial, DEVOTE study
BioAge Labs Files for $100 Million IPO to Advance Obesity Treatment Candidate Azelaprag
BioAge Labs, IPO, Obesity Treatment, Azelaprag, Eli Lilly, Novo Nordisk, Clinical Trials
Enhancing Flu Vaccine Uptake in the Post-Pandemic Era: Strategies and Insights
flu vaccine uptake, post-pandemic era, vaccine hesitancy, public health strategies, healthcare providers, influenza vaccination
FDA Authorizes Novavax’s Updated COVID-19 Vaccine for Emergency Use
Novavax COVID-19 Vaccine, FDA Authorization, Emergency Use, Protein-Based Vaccine, JN.1 Variant
EU High Court Rules in Favor of Illumina in Grail Acquisition Appeal
Illumina, Grail, European Court of Justice, Acquisition, Antitrust Litigation, Liquid Biopsy
Recursion’s Phase 2 Trial for Cerebral Cavernous Malformation Shows Limited Efficacy Despite Meeting Safety Goals
Recursion Pharmaceuticals, Phase 2 trial, cerebral cavernous malformation (CCM), REC-994, safety and tolerability, efficacy data, FDA meeting
Abbott MitraClip Demonstrates Significant Benefits in Treating Functional, Leaky Heart Valves
MitraClip, Abbott, Heart Valve Disease, Secondary Mitral Regurgitation, Transcatheter Mitral Valve Repair
Aixial Group Partners with Medidata to Enhance Clinical Trial Efficiency
Aixial Group, Medidata, clinical trial data, Single Source of Truth, data management, clinical research, patient data privacy, database lock.